Kristina A. Schulz-Tendl
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer.
Journal: Virchows Archiv : an international journal of pathology
Published: May 06, 2025
Risk Assessment Using Gene Expression Profiling Correlates with Clinical Prognosis Estimation in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer.
Journal: Breast care (Basel, Switzerland)
Published: September 27, 2024
Influence of histopathological changes after neoadjuvant chemotherapy on the survival of breast cancer patients.
Journal: Cancer treatment and research communications
Published: July 30, 2024
Neoadjuvant Therapy and Axillary Lymph Node Status in HER2-Positive Breast Cancer.
Journal: Cancer investigation
Published: July 18, 2023
Invasive lobular carcinoma: clinicopathological features and subtypes.
Journal: The Journal of international medical research
Published: June 30, 2021
"Anemia and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients".
Journal: Cancer investigation
Published: May 07, 2021
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab.
Journal: Therapeutic advances in medical oncology
Published: December 11, 2020
Androgen Receptor is Expressed in Breast Cancer Brain Metastases.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: November 01, 2020
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
Journal: Virchows Archiv : an international journal of pathology
Published: February 19, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026